DE69312698D1 - Trizyklische tachikinin-antagonisten, deren herstellung und diese enthaltende pharmazeutische präparate - Google Patents

Trizyklische tachikinin-antagonisten, deren herstellung und diese enthaltende pharmazeutische präparate

Info

Publication number
DE69312698D1
DE69312698D1 DE69312698T DE69312698T DE69312698D1 DE 69312698 D1 DE69312698 D1 DE 69312698D1 DE 69312698 T DE69312698 T DE 69312698T DE 69312698 T DE69312698 T DE 69312698T DE 69312698 D1 DE69312698 D1 DE 69312698D1
Authority
DE
Germany
Prior art keywords
tricyclic
tachikinin
antagonists
production
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69312698T
Other languages
English (en)
Other versions
DE69312698T2 (de
Inventor
Vincenzo Pavone
Angelina Lombardi
Carlo Pedone
Carlo Alberto Maggi
Laura Quartara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menarini Industrie Farmaceutiche Riunite SRL
Laboratorio Guidotti SpA
Malesci Instituto Farmacobiologico SpA
Original Assignee
Menarini Industrie Farmaceutiche Riunite SRL
Laboratorio Guidotti SpA
Malesci Instituto Farmacobiologico SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Industrie Farmaceutiche Riunite SRL, Laboratorio Guidotti SpA, Malesci Instituto Farmacobiologico SpA filed Critical Menarini Industrie Farmaceutiche Riunite SRL
Publication of DE69312698D1 publication Critical patent/DE69312698D1/de
Application granted granted Critical
Publication of DE69312698T2 publication Critical patent/DE69312698T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69312698T 1992-04-15 1993-04-13 Trizyklische tachikinin-antagonisten, deren herstellung und diese enthaltende pharmazeutische präparate Expired - Fee Related DE69312698T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITFI920089A IT1262902B (it) 1992-04-15 1992-04-15 Composti triciclici antagonisti delle tachichinine, loro preparazione e loro uso in composizioni farmaceutiche.
PCT/EP1993/000893 WO1993021227A1 (en) 1992-04-15 1993-04-13 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds

Publications (2)

Publication Number Publication Date
DE69312698D1 true DE69312698D1 (de) 1997-09-04
DE69312698T2 DE69312698T2 (de) 1997-12-04

Family

ID=11350056

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69312698T Expired - Fee Related DE69312698T2 (de) 1992-04-15 1993-04-13 Trizyklische tachikinin-antagonisten, deren herstellung und diese enthaltende pharmazeutische präparate

Country Status (28)

Country Link
EP (1) EP0636146B1 (de)
JP (1) JPH08500331A (de)
KR (1) KR950700935A (de)
CN (1) CN1039126C (de)
AT (1) ATE156135T1 (de)
AU (1) AU671118B2 (de)
BG (1) BG99110A (de)
BR (1) BR9306248A (de)
CA (1) CA2118253A1 (de)
CZ (1) CZ254294A3 (de)
DE (1) DE69312698T2 (de)
DK (1) DK0636146T3 (de)
ES (1) ES2105265T3 (de)
FI (1) FI944838A (de)
GR (1) GR3024348T3 (de)
HR (1) HRP930814A2 (de)
HU (1) HUT70189A (de)
IL (1) IL105381A (de)
IT (1) IT1262902B (de)
MX (1) MX9302161A (de)
NO (1) NO943861L (de)
NZ (1) NZ251969A (de)
RO (1) RO112872B1 (de)
RU (1) RU94045890A (de)
SK (1) SK124294A3 (de)
TW (1) TW234718B (de)
WO (1) WO1993021227A1 (de)
ZA (1) ZA932644B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277835B1 (it) * 1995-03-13 1997-11-12 Menarini Farma Ind Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
IT1283171B1 (it) * 1996-03-01 1998-04-16 Interdipartimentale Di Ricerca Composti solubili antagonisti delle tachichinine loro preparazione e loro uso in composizioni farmaceutiche
IT1291776B1 (it) 1997-02-07 1999-01-21 Menarini Ricerche Spa Composti monociclici a quattro residui bifunzionali, aventi azione nk-2 antagonista
IT1307809B1 (it) 1999-10-21 2001-11-19 Menarini Ricerche Spa Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono.
EP1297826A1 (de) * 2001-09-27 2003-04-02 Menarini Ricerche S.p.A. Pharmazeutische Zusammensetzung zur nasalen Verabreichung enthaltend einen NK-2 Antagonisten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8807246D0 (en) * 1988-03-25 1988-04-27 Merck Sharp & Dohme Therapeutic agents
DE3915361A1 (de) * 1989-05-11 1990-11-15 Merck Patent Gmbh Cyclopeptide

Also Published As

Publication number Publication date
HU9402977D0 (en) 1995-02-28
NZ251969A (en) 1997-12-19
CN1039126C (zh) 1998-07-15
NO943861D0 (no) 1994-10-13
BR9306248A (pt) 1998-06-23
EP0636146A1 (de) 1995-02-01
RU94045890A (ru) 1996-09-10
CA2118253A1 (en) 1993-10-28
ATE156135T1 (de) 1997-08-15
AU4039593A (en) 1993-11-18
FI944838A0 (fi) 1994-10-14
ES2105265T3 (es) 1997-10-16
JPH08500331A (ja) 1996-01-16
KR950700935A (ko) 1995-02-20
IT1262902B (it) 1996-07-22
ITFI920089A0 (it) 1992-04-15
WO1993021227A1 (en) 1993-10-28
AU671118B2 (en) 1996-08-15
ITFI920089A1 (it) 1993-10-15
SK124294A3 (en) 1995-07-11
NO943861L (no) 1994-10-13
GR3024348T3 (en) 1997-11-28
FI944838A (fi) 1994-10-14
MX9302161A (es) 1994-05-31
DK0636146T3 (da) 1998-02-23
RO112872B1 (ro) 1998-01-30
CZ254294A3 (en) 1995-07-12
ZA932644B (en) 1993-10-22
EP0636146B1 (de) 1997-07-30
HUT70189A (en) 1995-09-28
HRP930814A2 (en) 1996-12-31
DE69312698T2 (de) 1997-12-04
CN1080916A (zh) 1994-01-19
IL105381A (en) 1998-02-22
BG99110A (bg) 1995-09-29
TW234718B (de) 1994-11-21

Similar Documents

Publication Publication Date Title
ES2193142T3 (es) Uso de benzotiofenos para el tratamiento de hipercolesterolemia.
ATE104279T1 (de) 4-fluorbenzolderivate, herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen.
DE3581699D1 (de) Bis-dimethoxymethyl(trimethoxybenzyl)isochinolinium-salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69317877T2 (de) 4''-deoxyerythromycinderivate
DE59005304D1 (de) Benzolsulfonamide und Verfahren zu ihrer Herstellung.
ES2133295T3 (es) Peptidos ciclicos y su uso.
DZ1468A1 (fr) Composés nouveaux.
DE69312698D1 (de) Trizyklische tachikinin-antagonisten, deren herstellung und diese enthaltende pharmazeutische präparate
SE8207224L (sv) Nya aromatiska aminoalkoxiderivat, deras framstellning och deras terapeutiska anvendning
ES489521A0 (es) Un procedimiento para la preparacion de un peptido
ES2072332T3 (es) Derivados de la dibenzo(1,5)dioxocin-5-ona, su uso en medicamentos y procedimiento para su fabricacion.
GEP20002271B (en) Bicyclic Tachykinins Antagonists, Pharmaceutical Composition on Its Basis and Their Use
DE3770048D1 (de) Synergistin-derivate, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE68915094D1 (de) Benzofuranverbindungen, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische und kosmetische Zusammenstellungen und Verwendung dieser Zusammenstellungen.
DE69214747D1 (de) N-(Isochinolein-5-yl)-Sulfonyl Azazykloalkane, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
IL95384A0 (en) 1,3-oxazines,their preparation and pharmaceutical compositions containing them
FI911616A0 (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.
RU94020401A (ru) СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ β -ФЕНИЛ-ИЗОСЕРИНА И ПРОИЗВОДНЫЕ b -ФЕНИЛ-ИЗОСЕРИНА
RU93058547A (ru) Производные тиопиранопиррола, способ их получения и их применение
ATE37376T1 (de) Nonapeptid- und decapeptidanaloge von lhrh mit wirkung als lhrh antagonisten, ihre herstellung und diese enthaltende zusammensetzungen.
TH13833EX (th) สารประกอบ
UA15628A (uk) Засіб для лікуваhhя іhфіковаhих раh

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee